These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6726357)

  • 1. BCNU solubility and toxicity in the treatment of malignant astrocytomas.
    Layton PB; Greenberg HS; Stetson PL; Ensminger WD; Gyves JW
    J Neurosurg; 1984 Jun; 60(6):1134-7. PubMed ID: 6726357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCNU stability as a function of ethanol concentration and temperature.
    Tepe P; Hassenbusch SJ; Benoit R; Anderson JH
    J Neurooncol; 1991 Apr; 10(2):121-7. PubMed ID: 1895160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BCNU treatment of astrocytomas: erratum.
    Layton PB
    J Neurosurg; 1984 Sep; 61(3):621. PubMed ID: 6747712
    [No Abstract]   [Full Text] [Related]  

  • 4. pH-induced modification of BCNU toxicity on glial cells.
    Röttinger EM; Smith BD; Weidenmaier W
    Radiother Oncol; 1986 Jan; 5(1):23-7. PubMed ID: 3952346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats.
    Helal GK; Helal OK
    Arch Toxicol; 2009 Jan; 83(1):87-94. PubMed ID: 18528683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors.
    Aronin PA; Mahaley MS; Rudnick SA; Dudka L; Donohue JF; Selker RG; Moore P
    N Engl J Med; 1980 Jul; 303(4):183-8. PubMed ID: 7383088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained release of BCNU for the treatment of intraocular malignancies in animal models.
    Liu HS; Refojo MF; Perry HD; Albert DM
    Invest Ophthalmol Vis Sci; 1979 Oct; 18(10):1061-7. PubMed ID: 478776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo enhanced antitumor activity of carmustine [N,N'-bis(2-chloroethyl)-N-nitrosourea] by simvastatin.
    Soma MR; Baetta R; De Renzis MR; Mazzini G; Davegna C; Magrassi L; Butti G; Pezzotta S; Paoletti R; Fumagalli R
    Cancer Res; 1995 Feb; 55(3):597-602. PubMed ID: 7834630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracarotid BCNU (NSC-409962): a toxicity study in six rhesus monkeys.
    Crafts DC; Levin VA; Nielsen S
    Cancer Treat Rep; 1976 May; 60(5):541-5. PubMed ID: 825222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.
    Levin VA; Wilson CB; Davis R; Wara WM; Pischer TL; Irwin L
    J Neurosurg; 1979 Oct; 51(4):526-32. PubMed ID: 225456
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination chemotherapy with carmustine and cisplatin followed by procarbazine, lomustine, and vincristine for adult high-grade astrocytoma.
    Liau CT; Wei KC; Tseng CK; Jung SM
    Chang Gung Med J; 2005 Jan; 28(1):16-23. PubMed ID: 15804144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors.
    Levin VA; Crafts DC; Wilson CB; Schultz MJ; Boldrey EB; Enot KJ; Pischer TL; Seager M; Elashoff RM
    Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study.
    Kitamura I; Kochi M; Matsumoto Y; Ueoka R; Kuratsu J; Ushio Y
    Cancer Res; 1996 Sep; 56(17):3986-92. PubMed ID: 8752168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model.
    Bullard DE; Bigner SH; Bigner DD
    Cancer Res; 1985 Nov; 45(11 Pt 1):5240-5. PubMed ID: 4053004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial drug infusion with extracorporeal removal. II. Internal carotid carmustine in the rhesus monkey.
    Oldfield EH; Dedrick RL; Chatterji DC; Yeager RL; Girton ME; Kornblith PL; Doppman JL
    Cancer Treat Rep; 1985 Mar; 69(3):293-303. PubMed ID: 2983894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors.
    Sipos EP; Tyler B; Piantadosi S; Burger PC; Brem H
    Cancer Chemother Pharmacol; 1997; 39(5):383-9. PubMed ID: 9054951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of human brain tumor xenografts with O6-benzyl-2'-deoxyguanosine and BCNU.
    Schold SC; Kokkinakis DM; Rudy JL; Moschel RC; Pegg AE
    Cancer Res; 1996 May; 56(9):2076-81. PubMed ID: 8616853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute signs and symptoms of toxicity due to the BOPP regimen (BCNU, vincristine, procarbazine, cisplatin) during treatment of high-grade astrocytoma].
    Jeremić B; Grujicić D; Jevremović S; Mijatović Lj
    Srp Arh Celok Lek; 1991; 119(9-10):256-8. PubMed ID: 1806994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro analysis of BCNU-sensitivity in human malignant gliomas. I. A model study with alkylating, cross-linking and carbamoylating agents in anaplastic astrocytomas of pediatric age.
    Gerosa MA; Rosenblum ML; Stevanoni G; Tommasi M; Della Corte V; Licata C; Bricolo A; Tridente G
    Acta Neurol Scand; 1985 Oct; 72(4):414-8. PubMed ID: 3002083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of intracranial tumors with Nitrumon (Litrumon; BCNU; 1,3-bis (2-chlorethyl)-1-nitrosourea)].
    Cigánek L; Kalina P; Silvanová E
    Cesk Neurol Neurochir; 1979 Jul; 42(4):228-35. PubMed ID: 509621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.